The 2-Minute Rule for BI-2852
Within this examine we examined the action of cefepime/zidebactam (WCK 5222) against consecutive reference laboratory submissions of Gram-adverse microbes, taken as being a sample of challenge strains circulating in britain.infections. A latest indication formulates intermediate daily dosing as the optimum dosage of fosfomycin together therapy Duri